INVA Q2 2021 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$101M+27.7% YoY

Gross Profit

$101M100.0% margin

Operating Income

$97M95.8% margin

Net Income

$89M88.2% margin

EPS (Diluted)

$0.90

QoQ Revenue Growth

+17.9%

Cash Flow

Operating Cash Flow

$85M

Free Cash Flow

$85M

Stock-Based Comp.

$470,000

Balance Sheet

Total Assets

$789M

Total Liabilities

$395M

Stockholders' Equity

$330M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$101M	$79M	+27.7%
Gross Profit	$101M	$79M	+27.6%
Operating Income	$97M	$76M	+27.4%
Net Income	$89M	$77M	+15.8%

Revenue Segments

Royalty

$26M100%